Lori Koch
Director of Finance/CFO bij DUPONT DE NEMOURS, INC.
Vermogen: 8 M $ op 31-03-2024
Profiel
Momenteel bekleedt Lori D. Koch de functie van Chief Financial Officer & Executive Vice President bij DuPont de Nemours, Inc. en Director, Chief Financial Officer & Executive VP bij Nutrition & Biosciences, Inc. (een dochteronderneming van DuPont de Nemours, Inc.). Mevrouw Koch zit ook in de raad van bestuur van Aceto Corp. Mevrouw Koch is afgestudeerd aan het Babson College en heeft een bachelorgraad van de Pennsylvania State University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
DUPONT DE NEMOURS, INC.
0.02% | 02-03-2024 | 100 219 ( 0.02% ) | 8 M $ | 31-03-2024 |
Actieve functies van Lori Koch
Bedrijven | Functie | Begin |
---|---|---|
DUPONT DE NEMOURS, INC. | Director of Finance/CFO | 17-02-2020 |
ACETO CORPORATION | Director/Board Member | 01-12-2019 |
Nutrition & Biosciences, Inc.
Nutrition & Biosciences, Inc. Chemicals: Major DiversifiedProcess Industries Nutrition & Biosciences, Inc. manufactures and distributes food & beverages, dietary supplements, and pharmaceutical products. The company is headquartered in Wilmington, DE. | Director of Finance/CFO | - |
Eerdere bekende functies van Lori Koch
Bedrijven | Functie | Einde |
---|---|---|
E I DU PONT DE NEMOURS AND CO | Director of Finance/CFO | - |
Opleiding van Lori Koch
Babson College | Graduate Degree |
The Pennsylvania State University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
DUPONT DE NEMOURS, INC. | Process Industries |
Bedrijven in privébezit | 3 |
---|---|
Actylis Corp.
Actylis Corp. Pharmaceuticals: GenericHealth Technology Actylis Corp. engages in the development, marketing, sale, and distribution of chemical compounds used in the pharmaceutical, nutraceutical, agricultural, coatings, and industrial chemical industries. It operates through the following segments: Human Health, Pharmaceutical Ingredients, and Performance Chemicals. The Human Health segment develops and sells finished dosage form generic drugs and nutraceutical products. The Pharmaceutical Ingredients segment supplies active pharmaceutical ingredients and pharmaceutical intermediates. The Performance Chemicals segment comprises of specialty chemicals and agricultural protection products. The company was founded in 1947 and is headquartered in Port Washington, NY. | Health Technology |
EIDP, Inc.
EIDP, Inc. Chemicals: AgriculturalProcess Industries EIDP, Inc. engages in the provision of science-based products and services. It operates through the Seed and Crop Protection segments. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms around the world. The Crop Protection segment serves the global agricultural input industry with products that protect against weeds, insects and other pests, and disease, and that improve overall crop health both above and below ground via nitrogen management and seed-applied technologies. The company was founded by Eleuthere Irenee du Pont in 1802 and is headquartered in Indianapolis, IN. | Process Industries |
Nutrition & Biosciences, Inc.
Nutrition & Biosciences, Inc. Chemicals: Major DiversifiedProcess Industries Nutrition & Biosciences, Inc. manufactures and distributes food & beverages, dietary supplements, and pharmaceutical products. The company is headquartered in Wilmington, DE. | Process Industries |